2-Cyclopropyl-8-methylquinoline-4-carboxylic acid, 95%, 250mg

(3R,4R)-(3-HYDROXY-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 5g

3-Amino-N,N-dimethylbenzenesulfonamide, 95.0%, 1g

(2S)-2-benzyl-N,N-dimethylaziridine-1-sulfonamide, 97%, 1g

1-(5-Bromopyrimidin-2-yl)propan-1-one, 95.0%, 100mg

(3aR,3'aR,8aS,8'aS)-2,2'-Ethylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 97%, 5g

2-(3-(Cyclopropylmethoxy)-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

2-Chloro-4-fluorobenzamide, 97.0%, 5g

5-Methyl-4-phenyl-thiophene-3-carboxylic acid, 95.0%, 1g

Malonic acid dihydrazide, 99.0%, 25g

1-(tert-Butyl) 2-methyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidine-1,2-dicarboxylate, 95+%, 250mg

5,10,15,20-Tetra(pyridin-3-yl)porphyrin, 97%, 25g

tert-butyl (2R)-piperidine-2-carboxylate, 97%, 1g